The dopamine transporter (DAT) was localized in normal human brain tissue b
y light microscopic immunocytochemistry by using highly specific monoclonal
antibodies. Regional distribution of DAT was found in areas with establish
ed dopaminergic circuitry, e.g., mesostriatal, mesolimbic, and mesocortical
pathways. Mesencephalic DAT-immunoreactivity was enriched in the dendrites
and cell bodies of neurons in the substantia nigra pars compacta and ventr
al tegmental area. Staining in the striatum and nucleus accumbens was dense
and heterogeneous. Mesocortical DAT immunoreactivity in motor, premotor, a
nterior cingulate, prefrontal, entorhinal/perirhinal, insular, and visual c
ortices was detected in scattered varicose and a few nonvaricose fibers. Va
ricose fibers were relatively enriched in the basolateral and central subnu
clei of amygdala, with sparser fibers in lateral and basomedial subnuclei.
Double-labeling studies combining DAT and tyrosine hydroxylase (TH) immunos
taining in the ventral mesencephalon showed two subpopulations of dopaminer
gic neurons differentiated by the presence or absence of DAT-immunoreactivi
ty in the A9 and A10 cell groups. In other dopaminergic cell groups (A11, A
13-A15), TH-positive hypothalamic neurons showed no detectable DAT-immunore
activity. However, fine DAT-immunoreactive axons were scattered throughout
the hypothalamus, particularly concentrated along the medial border, with m
ore coarse axons present along the lateral border. These findings demonstra
te that most mesotelencephalic dopamine neurons of human brain express high
levels of DAT throughout their entire somatodendritic and axonal domains,
whereas a smaller subpopulation of mesencephalic dopamine cells and all hyp
othalamic dopamine cell groups examined express little or no DAT These data
indicate that different subpopulations of dopaminergic neurons use differe
nt mechanisms to regulate their extracellular dopamine levels. (C) 1999 Wil
ey-Liss, Inc.